425: Strive CEO Posts on X.com Regarding Semler Merger

Strive's CEO, Matthew Cole, posted on X.com about the proposed business combination with Semler Scientific, Inc.

Summary

• This communication, posted by Strive's CEO Matthew Cole on X.com on October 28, 2025, relates to Strive's proposed business combination with Semler Scientific, Inc.
• The document serves as a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the proposed transaction.
• It outlines various factors that could cause actual results to differ materially from anticipated outcomes, including risks related to closing conditions, integration, and financial performance.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders.
• Stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when available, as they will contain important information about both companies and the proposed transaction.
• Information regarding participants in the solicitation of proxies, including directors and executive officers of both companies, will be detailed in the Information Statement/Proxy Statement/Prospectus.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed business combination, outlining numerous risks without providing specific positive or negative financial results or operational updates. It is neutral in tone, focusing on regulatory compliance and risk disclosure.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected to impact the combined company's future financial performance positively.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement by either Strive or Semler Scientific.
• The possibility that the proposed transaction may not close when expected or at all due to unfulfilled closing conditions.
• The outcome of any legal proceedings that may be initiated against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and regulatory enforcement.
• The integration of the two companies may prove more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution for existing shareholders caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from customers of Strive or Semler Scientific, or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The proposed transaction is expected to result in strategic and financial benefits for the combined company, including positive impacts on future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, and actual results could differ materially.

Management Comments

• Matthew Cole, CEO of Strive, Inc., communicated about the proposed business combination with Semler Scientific, Inc. via X.com on October 28, 2025.

Industry Context

The filing does not provide specific industry context or analysis of broader industry trends, focusing solely on the proposed business combination and its associated risks.

Stakeholder Impact

• Potential adverse reactions from customers of Strive or Semler Scientific.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for shareholders of Strive due to the issuance of additional Class A common stock.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Strive Inc., Semler Scientific Inc., Form 425, Forward-Looking Statements, Risk Factors, Stockholder Approval, Bitcoin Treasury Strategy